Cidara Therapeutics (CDTX) filed a registration statement Monday with the US Securities and Exchange Commission covering the potential resale of up to 7.04 million common shares by certain stockholders from time to time.

The company said that 3.89 million of the shares are issued and outstanding, while the remaining are issuable upon the exercise of prefunded warrants.

Cidara isn't selling any shares under the statement and won't receive any proceeds from the sale by the investors.

The company's shares fell 1.7% in after-hours activity.

Price: 23.01, Change: -0.39, Percent Change: -1.67